Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    20-June-2000      
Issue 68 Next Update - 14:00 UTC 08:00 EST    21-June-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Research For Sale

Boston University Will Sell Framingham Heart Study Data

Boston University has struck a deal that would allow a new company to sell analyses of data from the university's Framingham Heart Study, pioneering research into heart attacks and strokes that has been going on for more than half a century.

The study has amassed a huge collection of genetic, clinical and behavioral data from the 10,000 participants, all families from the western Boston suburb.

The university will own 20 percent of the new company, Framingham Genomic Medicine Inc. Venture capitalists have committed $21 million to form the company.

Pharmaceutical and biotechnology companies are expected to pay annual fees to access the medical information, which will be placed in a huge electronic database, the Boston Globe reported Friday.

University spokesman David Lampe said Friday the company would sell analyses of the data, not the data itself, which is already free to researchers.

"All the data is available to everyone for free. It always has been. It always will be," said David Lampe. "We are not selling any Heart Study data for a profit, only the analyses."

The university said patient privacy would be protected. Only two of the study's 6,000 surviving participants have asked that their records be excluded.

Dr. Fred Ledley, Framingham Genomic Medicine's chief scientific officer, said the forthcoming release of the first draft of the human genome _ the mapping of more than 100,000 genes _ means the database will be a resource for pharmaceutical researchers looking to identify the connection between specific genes, and health and disease outcomes.

Ledley said stock in the company would be put in a charitable trust for the benefit of the city of Framingham. Lampe said the company also would help fund an ethics advisory board and science education in the city's schools.

Dr. Claude Lenfant, director of the National Heart, Lung and Blood Institute, which has contributed more than $40 million to the heart study, expressed reservations about the proposal, saying he didn't want one company to have exclusive access to the data.

"This data was obtained with public money. Why should we give access to one person or one company?" he asked.

He said agency lawyers were reviewing the institute's agreement with BU, and still sorting out who owns which portion of the heart study data.

The Framingham Heart Study has been collecting data for 52 years, accumulating vast amounts of information, including 500,000 chest X-rays and electrocardiograms, 5,000 blood samples and truckloads of paper medical records that include diet diaries and even early studies of male balding patterns.

More than 1,000 published studies have stemmed from the data collected from Framingham residents on their lifestyle and health patterns. Among the basic concepts that scientists have learned from them over the years are the roles of smoking and cholesterol in heart disease.


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.